Description
EXPRESS REPORT: FOR PHARMACY ORDERING OFFICER ORDERS FOR DUOPA FOR FY18
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-10-02+$53,903= $53,903
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-10-02 | +$53,903 | $53,903 | EXPRESS REPORT: FOR PHARMACY ORDERING OFFICER ORDERS FOR DUOPA FOR FY18 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NDN1MYB8DKK5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726D0033 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79725D0054 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79723D0015 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36F79723D0025 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79722D0014 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| 36E79721N0050 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726P0690 | SINA DRUG LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $188,463 | FY2026 |
| 36C24726N0211 | BOSTON SCIENTIFIC CORP | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $248,982 | FY2026 |
| 36C24726F0100 | AMICUS THERAPEUTICS US, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $228,396 | FY2026 |
| 36C24726F0053 | EXELAN PHARMACEUTICALS INC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $4,765,853 | FY2026 |
| 36C24726F0043 | AMICUS THERAPEUTICS US, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $109,456 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24718K0034_3600_VA797P15D0032_3600 · retrieved 2026-09-26.